Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feilin Cao

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Frontiers in Cell and Developmental Biology|December 27, 2021
Deoxyribonucleic Acid 5-Hydroxymethylation in Cell-Free Deoxyribonucleic Acid, a Novel Cancer Biomarker in the Era of Precision MedicineLing Xu, Yixin Zhou, Lijie Chen, et al.
Biomarkers in Medicine|March 26, 2025
5-Hydroxymethylcytosine signatures in circulating cell-free DNA as potential diagnostic markers for breast cancerNadire Aishan, Siwei Ju, Zhongqiu Zheng, et al.
Elife|April 3, 2025
Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (PERSIST): A multicenter phase II trialFeilin Cao, Zhaosheng Ma, Zenggui Wu, et al.
Frontiers in Oncology|December 12, 2024
EGFR and MUC1 as dual-TAA drug targets for lung cancer and colorectal cancerHuilin Cui, Qianqian Yu, Qumiao Xu, et al.
Signal Transduction and Targeted Therapy|February 16, 2025
ACE-Breast-02: a randomized phase III trial of ARX788 versus lapatinib plus capecitabine for HER2-positive advanced breast cancerXichun Hu, Qingyuan Zhang, Leiping Wang, et al.
Science China. Life Sciences|July 14, 2021
Proteomics provides individualized options of precision medicine for patients with gastric cancerWenwen Huang, Dongdong Zhan, Yazhuo Li, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Frontiers in Cell and Developmental Biology|December 27, 2021
Deoxyribonucleic Acid 5-Hydroxymethylation in Cell-Free Deoxyribonucleic Acid, a Novel Cancer Biomarker in the Era of Precision MedicineLing Xu, Yixin Zhou, Lijie Chen, et al.
Biomarkers in Medicine|March 26, 2025
5-Hydroxymethylcytosine signatures in circulating cell-free DNA as potential diagnostic markers for breast cancerNadire Aishan, Siwei Ju, Zhongqiu Zheng, et al.
Elife|April 3, 2025
Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (PERSIST): A multicenter phase II trialFeilin Cao, Zhaosheng Ma, Zenggui Wu, et al.
Frontiers in Oncology|December 12, 2024
EGFR and MUC1 as dual-TAA drug targets for lung cancer and colorectal cancerHuilin Cui, Qianqian Yu, Qumiao Xu, et al.
Signal Transduction and Targeted Therapy|February 16, 2025
ACE-Breast-02: a randomized phase III trial of ARX788 versus lapatinib plus capecitabine for HER2-positive advanced breast cancerXichun Hu, Qingyuan Zhang, Leiping Wang, et al.
Science China. Life Sciences|July 14, 2021
Proteomics provides individualized options of precision medicine for patients with gastric cancerWenwen Huang, Dongdong Zhan, Yazhuo Li, et al.
Pageof 4